ASH 2022 Conference Coverage
ASH 2022 Myeloma XI Trial: Defining the Optimal Duration of Lenalidomide Maintenance After ASCT
By
ASH 2022 Conference Coverage
FEATURING
Gareth Morgan
By
ASH 2022 Conference Coverage
FEATURING
Gareth Morgan
Login to view comments.
Click here to Login